Daplyza [Dapagliflozin] 5mg tablets

 310

20 People watching this product now!

Payment Methods:

Description

Daplyza [Dapagliflozin] 5mg Tablets – Effective Management of Type 2 Diabetes

Daplyza is a medication containing Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, used to manage type 2 diabetes mellitus. orks by preventing glucose reabsorption in the kidneys, thereby lowering blood sugar levels.

dications*

Daply is prescribed for:

  • rovg Glycemic Control: As an adjunct to diet and exercise in adults with type 2 diabetes mellitus.
  • Redug rdiovascular Risk: To lower the risk of hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors.
  • Heart FurManagement: To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) and reduced ejection fraction.
  • Chronic Kiy sease: To decrease the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression. ([getzpharma.com]ttps://getzpharma.c/product/daplyza/?utm_source=chatg.com))

Dosage and Administration

  • Dosage: Typically, one 5mg tablet is ta oe daily, preferably in the morning.
  • Administration: Swallow the tablet whole with la of water, with or without food.
  • Renal Impairment: Daplyza is not recommended for use to improve glycemic control in adults with type 2 diabetes mellitus with eGFR less than 45 /min/1.73 m². (getharma.com)

Side Effects

Common side effects may include:

  • Urinary tract infections creased urination
  • Thirst

Serious side effects are rare but can include dehydration, hypotension, and kidney problems. If you experie symptoms such as dziness, lightheadedness, or signs of a urinary tract infection, contact r althcare provider.

Precautions

  • Pregnancy and Lactation: Consult your healthcare provider before use.
  • Liver Impairment: No dosage adjustment is necessary for milto moderate hepaticmprment. In patients with severe hepatic impairment, a starting dose of 5mg is recommended. (getzpharma.com)
  • Drnteractions: Inform your doctor about all cations you are taking, including over-the-counter drugs and sulements.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Daplyza [Dapagliflozin] 5mg tablets”

Your email address will not be published. Required fields are marked *

1 2 3 4 5
1 2 3 4 5
1 2 3 4 5